Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material

Biotechnology and Bioengineering

Volumn 87, Issue 7, 2004, Pages 863-873

  Cheng, S Y ^a,b   Gross, J ^b   Sambanis, A ^a,b  

^a Georgia Institute of Technology   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

TC3 insulinomas; Concanavalin A; Insulin secretion; Pancreatic substitute; Sol gel transformation

Indexed keywords

CELLS; DIFFUSION; GLUCOSE; INSULIN; MECHANICAL PERMEABILITY; MEMBRANES; PATHOLOGY; POLYCARBONATES; SOL-GELS; TISSUE;

PANCREATIC SUBSTITUTE; PATHOLOGICAL CONDITIONS; SOL GEL TRANSFORMATIONS;

BIOMEDICAL ENGINEERING;

ALGINIC ACID; CONCANAVALIN A; FLUORESCEIN ISOTHIOCYANATE; GLUCOSE; GLYCOGEN; INSULIN; POLYCARBONATE;

ANIMAL CELL; ARTICLE; AUTOGRAFT; CELL DENSITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GEL; GENETIC ENGINEERING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PANCREATIC TISSUE SUBSTITUTE; PERMEABILITY; SOLID; TISSUE ENGINEERING;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COATED MATERIALS, BIOCOMPATIBLE; CONCANAVALIN A; DIFFUSION; GLUCOSE; INSULIN; INSULINOMA; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; MICE; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PANCREAS, ARTIFICIAL; PERMEABILITY; PHASE TRANSITION; RECOMBINATION, GENETIC; TISSUE ENGINEERING;

ANIMALIA;

EID: 4644245488     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.20195     Document Type: Article

References (41)

1. American Diabetes Association. 2003. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932.
2. Bittiger H, Schnebli HP. 1976. Concanavalin A as a tool. New York/Chichester: Wiley.
3. Brown L, Mathiowitz E, Brandenburg D, Langer R. 1988. Enzymatically controlled drug delivery. Proc Natl Acad Sci 85:2403-2406.
4. Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986.
5. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S. 1988. Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85:9037-9041.
6. Efrat S, Surana M, Fleischer N. 1991. Glucose induces insulin gene transcription in a murine pancreatic beta- cell line. J Biol Chem 266:11141-11143.
7. Hisamitsu I, Kataoka K, Okano T, Sakurai Y. 1997. GLucose-responsive gel from phenylborate polymer and poly(vinyl alcohol): Prompt response at physiological pH through the interaction of borate with amino group in the gel. Pharm Res 14:289-293.
8. Kataoka K, Miyazaki H, Bunya M, Okano T, Sakurai Y. 1998. Totally synthetic polymer gels responding to external glucose concentration: Their preparation and application to on-off regulation of insulin release. J Am Chem Soc 120:12694-12695.
9. Kataoka K, Miyazaki H, Miyaji K, Hisamitsu I, Tanaka K, Okano T, Sakurai Y. 1994. Novel glucose-sensitive polymers and hydrogels based on phenylborate containing polymers. Polymer Preprints 35:393-394.
10. Kikuchi A, Okano T. 2002. Pulsatile drug release control using hydrogels. Adv. Drug Delivery Rev 54:53-77.
11. Kim JJ, Park K. 2001. Glucose-binding property of pegylated concanavalin A. Pharm Res 18:794-799.
12. Kost J, Horbett TA, Ratner BD, Singh M. 1985. Glucose-sensitive membranes containing glucose oxidase: Activity, swelling, and permeability studies. J Biomed Mater Res 19:1117-1133.
13. Lee HC, Kim SJ, Kim KS, Shin HC, Yoon JW. 2000. Remission in models of type 1 diabetes by gene therapy using a single- chain insulin analogue. Nature 408:483-488.
14. Malikkides C, Weiland R. 1982. On the mechanism of immobilized glucose oxidase deactivation by hydrogen peroxide. Biotechnol Bioeng 24:2419-2439.
15. Miyata T, Jikihara A, Nakamae K, Hoffman AS. 1996. Preparation of poly (2-glucosyloxyethyl methacrylate)-concanavalin A complex hydrogel and its glucose-sensitivity. Macromol Chem Phys 197:1135-1146.
16. Nakamae K, Miyata T, Jikihara. A, Hoffman AS. 1994. Formation of poly(glucosyloxyethyl methacrylate)-concanavalin A complex and its glucose-sensitivity. J Biomater Sci Polym Ed 6:79-90.
17. Obaidat AA, Park K. 1997. Characterization of protein release through glucose-sensitive hydrogel membranes. Biomaterials 18(11):801-806.
18. Podual K, Doyle FJ III, Peppas NA. 2000a. Dynamic behavior of glucose oxidase-containing microparticles of poly(ethylene glycol)-grafted cationic hydrogels in an environment of changing pH. Biomaterials 21:1439-1450.
19. Podual K, Doyle FJ III, Peppas NA. 2000b. Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts. J Control Release 67:9-17.
20. Podual K, Doyle FJ III, Peppas NA. 2000c. Preparation and dynamic response of cationic copolymer hydrogels containing glucose oxidase. Polymer 41:3975-3983.
21. Qiu Y, Park K. 2001. Environment-sensitive hydrogels for drug delivery. Advanced Drug Delivery Reviews 53:321-339.
22. Sambanis A, Tan SA. 1999. Quantitative modeling of limitations caused by diffusion. In: Morgan JR, Yarmush ML, editors. Methods in molecular medicine, Vol. 18: Tissue engineering methods and protocols. Totowa, NJ: Humana Press.
23. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238.
24. Shapiro AM, Ryan EA, Lakey JR. 2001a. Clinical islet transplant - State of the art. Transplant Proc 33:3502-3503.
25. Shapiro AM, Ryan EA, Lakey JR. 2001b. Pancreatic islet transplantation in the treatment of diabetes mellitus. Best Pract Res Clin Endocrinol Metab 15:241-264.
26. Shiino D, Murata Y, Kataoka K, Koyama Y, Yokoyama M, Okano T, Sakurai Y. 1994. Preparation and characterization of a glucose-responsive insulin-releasing polymer device. Biomaterials 15:121-128.
27. Shiino D, Murata Y, Kubo A, Kim Y, Kataoka K, Koyama K, Kikuchi A, Yokoyama M, Sakurai Y, Okano T. 1995. Amine containing phenylboronic acid gel for glucose-responsive insulin release under physiological pH. J Control Rel 37:269-276.
28. Simonson GD, Groskreutz DJ, Gorman CM, MacDonald MJ. 1996. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum Gene Ther 7:71-78.
29. Stabler C, Wilks K, Sambanis A, Constantinidis I. 2001. The effects of alginate composition on encapsulated betaTC3 cells. Biomaterials 22:1301-1310.
30. Tang S-C, Sambanis A. 2003. Preproinsulin mRNA engineering and its application to the regulation of insulin secretion from human hepatomas. FEBS Lett 537:193-197.
31. Tanna S, Sahota T, Clark J, Taylor MJ. 2002a. Covalent coupling of concanavalin A to a Carbopol 934P and 941P carrier in glucose-sensitive gels for delivery of insulin. J Pharm Pharmacol 54:1461-1469.
32. Tanna S, Sahota T, Clark J, Taylor MJ. 2002b. A covalently stabilised glucose responsive gel formulation with a Carbopol carrier. J Drug Target 10:411-418.
33. Tanna S, Taylor MJ. 1998. Characterization of model solute and insulin delivery across covalently modified lectin-polysaccharide gels sensitive to glucose. Pharm Pharmacol Commun 4:117-122.
34. Tanna S, Taylor MJ, Adams G. 1999. Insulin delivery governed by covalently modified lectin-glycogen gels sensitive to glucose. J Pharm Pharmacol 51:1093-1098.
35. Taylor MJ, Tanna S, Taylor PM, Adams G. 1995. The delivery of insulin from aqueous and non-aqueous reservoirs governed by a glucose sensitive gel membrane. J Drug Target 3:209-216.
36. Thule PM, Liu J, Phillips LS. 2000. Glucose regulated production of human insulin in rat hepatocytes. Gene Ther 7:205-214.
37. Thule PM, Liu JM. 2000. Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther 7:1744-1752.
38. Traitel T, Cohen Y, Kost J. 2000. Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions. Biomaterials 21:1679-1687.
39. Tziampazis E, Sambanis A. 1995. Tissue engineering of a bioartificial pancreas: Modeling the cell environment and device function. Biotechnol Prog 11:115-126.
40. Yanagita M, Hoshino H, Nakayama K, Takeuchi T. 1993. Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines. Endocrinology 133:639-644.
41. Yanagita M, Nakayama K, Takeuchi T. 1992. Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7. FEBS Lett 311:55-59.